| Literature DB >> 16706630 |
Gethin Williams1, Matthew R Palmer, J Anthony Parker, Robin Joyce.
Abstract
The occurrence of radiation necrosis to the extravasation of therapeutic radionuclide-yttrium-90-ibritumomab tiuxetan-is described, as well as the subsequent steps taken to both address the occurrence and to prevent the re-occurrence of such an adverse event. Published reports on the extravasation of diagnostic and therapeutic radionuclides are reviewed, as are prevention and treatment protocols.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16706630 DOI： 10.1089/cbr.2006.21.101
Source DB: PubMed Journal: Cancer Biother Radiopharm ISSN： 1084-9785 Impact factor: 3.099